Suppr超能文献

胃癌前病变发生发展中的遗传因素——幽门螺杆菌的作用?

Genetic factors in the development of gastric precancerous lesions--a role of Helicobacter pylori ?

作者信息

Jablonská M, Chlumská A

机构信息

IVth Medical Clinic, Charles University, Prague, Czech Republic.

出版信息

J Physiol Paris. 2001 Jan-Dec;95(1-6):477-81. doi: 10.1016/s0928-4257(01)00066-3.

Abstract

UNLABELLED

Helicobacter pylori is believed to predispose to gastric cancer by inducing gastric precancerous alterations. There is a well known predisposition to gastric cancer and the risk of developing it is greater in relatives of patients with familial cases of this malignancy. The aim of this study was to determine the prevalence of gastric precancerous lesions (atrophy and intestinal metaplasia) and their association with Hp infection in first-degree relatives in patients with noncardia gastric cancer.

METHODS

Hp status and gastric histology assessed by upper gastrointestinal endoscopy, biopsies from the antral and body region, the rapid urease test and staining for Hp, inflammation, activity, atrophy and intestinal metaplasia (prevalence and grading) were studied in 108 first-degree relatives of patients with noncardia gastric cancer and compared with 73 controls with mild non-ulcer dyspepsia who had no cancer relatives and were examined in the same way.

RESULTS

subjects with and without cancer relatives had a similar prevalence of Hp infection (49 vs. 47%). Endoscopy revealed a few asymptomatic duodenal ulcers and small hiatus hernias in Hp positive subjects of both groups. Hp positive relatives of gastric cancer had a markedly higher prevalence of atrophy than those with Hp negativity without cancer relatives (29 vs. 9%) and those with Hp negativity and cancer relatives (29 vs. 3%. Prevalence of intestinal metaplasia was also higher in those with Hp positivity and cancer relatives than in those without cancer relatives (15 vs. 5% and was not present in Hp negative subjects with cancer relatives. Inflammation and activity showed similar scores in subjects with and without cancer relatives with higher scores in both Hp positive groups. The prevalence of precancerous lesions in the relatives of gastric cancer was nearly always confined to those with Hp positivity. One year after eradication the prevalence of atrophy in cancer relatives decreased from 29 to 14%; prevalence of intestinal metaplasia remained without substantial changes. Scores for inflammation and activity were also lower after eradication.

CONCLUSIONS

First-degree relatives of patients with gastric cancer have an increased prevalence of gastric precancerous abnormalities which are strongly confined to those with Hp infection. Eradication of Hp in these subjects with cancer relatives reduces the prevalence of precancerous lesions (atrophy) and grades of inflammation and activity. In view of these results, eradication of Hp should be offered to such subjects.

摘要

未标记

幽门螺杆菌被认为通过诱导胃部癌前病变而引发胃癌。胃癌存在众所周知的遗传易感性,在这种恶性肿瘤家族性病例患者的亲属中患癌风险更高。本研究的目的是确定非贲门胃癌患者一级亲属中胃癌前病变(萎缩和肠化生)的患病率及其与幽门螺杆菌感染的关联。

方法

对108例非贲门胃癌患者的一级亲属进行幽门螺杆菌状态和胃组织学评估,通过上消化道内镜检查、取自胃窦和胃体区域的活检、快速尿素酶试验以及幽门螺杆菌、炎症、活性、萎缩和肠化生(患病率和分级)染色,并与73例无癌症亲属且患有轻度非溃疡性消化不良并以相同方式检查的对照组进行比较。

结果

有癌症亲属和无癌症亲属的受试者幽门螺杆菌感染患病率相似(49%对47%)。内镜检查发现两组幽门螺杆菌阳性受试者中均有一些无症状十二指肠溃疡和小裂孔疝。胃癌幽门螺杆菌阳性亲属的萎缩患病率明显高于无癌症亲属的幽门螺杆菌阴性者(29%对9%)以及有癌症亲属的幽门螺杆菌阴性者(29%对3%)。幽门螺杆菌阳性且有癌症亲属者的肠化生患病率也高于无癌症亲属者(15%对5%),且有癌症亲属的幽门螺杆菌阴性受试者中不存在肠化生。有癌症亲属和无癌症亲属的受试者炎症和活性评分相似,两组幽门螺杆菌阳性者评分更高。胃癌亲属中癌前病变的患病率几乎总是局限于幽门螺杆菌阳性者。根除幽门螺杆菌一年后,癌症亲属中萎缩的患病率从29%降至14%;肠化生患病率无实质性变化。根除后炎症和活性评分也降低。

结论

胃癌患者的一级亲属中胃癌前异常的患病率增加,且强烈局限于幽门螺杆菌感染者。在这些有癌症亲属的受试者中根除幽门螺杆菌可降低癌前病变(萎缩)的患病率以及炎症和活性分级。鉴于这些结果,应向此类受试者提供幽门螺杆菌根除治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验